BIA Presses New UK Government On No-Deal Brexit Preparations
The life sciences industry has given a cautious welcome to the prime minister’s promises that the sector will be a priority once the UK leaves the EU, but has urged the new UK government to take steps to protect medicine supply chains in the event of a no-deal Brexit.
You may also be interested in...
BioIndustry Association wants more information about the UK government’s latest £2.1bn investment to fund preparations for a no-deal Brexit.
The UK has a new prime minister in Boris Johnson, who is likely to surround himself with strongly pro-Brexit ministers. The life sciences industry will need to continue lobbying for its interests to be protected in the event of a no-deal exit.
A European Parliament committee says that some aspects of the EU’s proposed unitary supplementary protection certificate scheme could promote access to cheaper off-patent medicines while others could delay generic competition.